Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
244 Leser
Artikel bewerten:
(0)

Cyient Recognized as a "Major Contender" in Everest Group's PEAK Matrix: Medical Device Engineering Services Assessment 2019

~The recognition further strengthens Cyient's position as a leading global medical technology and healthcare solutions provider ~

HYDERABAD, India, Feb. 15, 2019 /PRNewswire/ -- Cyient, a global provider of engineering, manufacturing, geospatial, networks, digital, and operations management solutions to global industry leaders, has been positioned as a "Major Contender" in the Everest Group Medical Device Engineering Services PEAK Matrix 2019 assessment.

Maximizing the ROI of Your IoT Initiatives and Connected Assets (PRNewsFoto/Cyient)

In its inaugural research report pertaining to the medical device engineering industry, Everest Group, a global consulting and outsourcing advisory firm, conducted an objective, data-driven, and comparative assessment of 12 global services providers in the medical devices engineering space across software services, embedded and electronic hardware services, and mechanical devices services based on their absolute market success and delivery capability.

"The medical technology and healthcare team has invested in expanding Cyient's capabilities to align with evolving medical devices industry trends. New acquisitions, product partnerships, industry consortia, IP incubation, and lab infrastructure are helping Cyient develop integrated solutions that encompass design engineering, testing and certification, and manufacturing. We are honored to be included in Everest Group's assessment and achieving "Major Contender" recognition, especially considering Everest Group's strong legacy in the life sciences and healthcare domain," said Brian Wyatt, Senior Vice President, Medical Technology and Healthcare Business Unit, Cyient.

Medical Technology & Healthcare is a fast growing space for Cyient. Besides working with several large OEM clients, Cyient has forged strategic collaborations with international bodies such as Xynteo, medical institutes such as LV Prasad Eye Institute, major hospital chains, product partnerships with firms like ANSYS, corporate venture investments, IP incubation, as well as acquisitions in certification & testing and industry-specific ASIC applications. These investments are helping Cyient transform into a design, build and maintain partner for global clients.

Learn more about Everest Group's PEAK Matrix

About Cyient:

Cyient (Estd: 1991, NSE: CYIENT) provides engineering, manufacturing, geospatial, networks, digital, and operations management solutions to global industry leaders. Cyient leverages the power of digital technology and advanced analytics capabilities, along with their domain knowledge and technical expertise, to help clients solve complex business problems. As a Design, Build, maintain partner that takes solution ownership across the value chain, Cyient empowers its clients to focus on their core, innovate, and stay ahead of the curve.

Relationships form the core of how Cyient works. With a client-centric approach and a workforce of more than 15,000 in 22 countries, Cyient combines global delivery with proximity to its clients to function as their extended team. Cyient's industry focus includes aerospace and defense, medical, telecommunications, rail transportation, semiconductor, utilities, industrial, energy and natural resources.

For more information, please visit www.cyient.com
Follow news about the company at @Cyient

For further media inquiries, please write to meeta.singh@cyient.com

Logo - https://mma.prnewswire.com/media/289359/cyient_logo.jpg

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.